MedTrace Logo

Assessment of the Safety of ABT-308 in Healthy Volunteers and Subjects With Asthma

NCT00986037 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 47

Last updated 2017-11-21

No results posted yet for this study

Summary

The primary purpose of this study is to determine the safety, tolerability and pharmacokinetics of ABT-308 in healthy volunteers and patients with mild to moderate controlled asthma.

Conditions

Interventions

DRUG

ABT-308

Single IV doses

DRUG

ABT-308

Multiple SC doses x 3

DRUG

Placebo

Single IV dose

DRUG

Placebo

Multiple SC doses x 3

Sponsors & Collaborators

Principal Investigators

  • Andrew Campbell, MD · Abbott

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
TRIPLE
Model
SINGLE_GROUP

Eligibility

Min Age
18 Years
Max Age
55 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2009-10-31
Primary Completion
2010-07-31

More Related Trials

Entities

Drugs
Diseases
Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00986037 on ClinicalTrials.gov